BioCryst Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6-$11.31 |
Market Cap | $2.3B |
Shares Short | 36M |
Financials
See moreRevenue (12 Mos) | $885.7M |
Revenue Growth (YoY) | 7.5% |
Gross Profit (12 Mos) | $678.6M |
Diluted EPS | -$1.77 |
News
See moreYahoo Finance • 24 days ago
BioCryst Pharmaceuticals Q1 Earnings Call Highlights
Yahoo Finance • last month
Organon (OGN) Takeover Bid Climbs to $13B, Shares Soar 30.9%
Yahoo Finance • last month
BioCryst to Report First Quarter 2026 Financial Results on May 6
Yahoo Finance • 2 months ago
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
About
CEO | Mr. Charles K. Gayer |
CFO | Mr. Babar Ghias |
Address | 4505 Emperor Boulevard, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 435 |